Nuvalent Inc. has identified proto-oncogene tyrosine-protein kinase ROS (ROS1; MCF3) and/or ALK tyrosine kinase receptor inhibitors reported to be useful for the treatment of cancer.

Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is an important oncofetal protein and a target of clinical relevance in MCL. It was previously attributed to a bypass resistance mechanism to ...

Baylor College of Medicine, Houston, TX.

Zai Lab Limited (NASDAQ:ZLAB) said on Monday that China’s National Medical Products Administration has accepted the label ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has ...

L-tyrosine, also simply known as tyrosine, is an amino acid and a building block our bodies use to produce protein. Though our bodies make tyrosine from another amino acid called phenylalanine, it has ...

Sutro Biopharma, Inc.’s STRO share price has dipped by 21.92%, which has investors questioning if this is right time to buy.

Zai Lab (ZLAB) announced that China’s National Medical Products Administration has accepted the supplemental new drug application for ...

Inhibikase Therapeutics, Inc.’s IKT share price has dipped by 5.09%, which has investors questioning if this is right time to ...

Zai Lab Limited (NASDAQ: ZLAB) shares barely moved Monday, on word China’s National Medical Products Administration (NMPA) has accepted the supplemental New Drug Application (sNDA) for repotrectinib ...